Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

More in Endocrinology

According to an article published by Reuters, Novo Nordisk is in the process of developing the world’s first once-weekly insulin injection. Still in initial Phase I clinical testing, the product is not expected to be available to the market before...
Tresiba, Novo Nordisk‘s new insulin has been shown to be both safe and effective for use in children and young adults with type 1 diabetes, a Reuters article says. According to a recent trial, children ages 1 to 18 years showed improvement in blood...
According to results from recent clinical trials, the new insulin drug from Biodel Incorporated for type 2 diabetes patients is more effective than current treatments, reports Reuters. The drug named BIOD-531 was compared to Eli Lilly and Company’s...